Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NID-2: Intensive Multifactorial Intervention in Diabetic Nephropathy
NCT00535925Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Oct 2005
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of irbesartan, ramipril, hydrochlorothiazide, furosemide, amlodipine in diabetic nephropathy (DN), type 2 diabetes mellitus (T2DM), hypertension (HTN), hypercholesterolemia, hypertriglyceridemia, sponsored by University of Campania Luigi Vanvitelli. Started Oct 2005; status: completed.
02
Drugs
irbesartanramiprilhydrochlorothiazidefurosemideamlodipine
03
Conditions
diabetic nephropathy (DN)type 2 diabetes mellitus (T2DM)hypertension (HTN)hypercholesterolemiahypertriglyceridemia
Beyond the preview
Go deeper on NCT00535925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535925.